Authors:
STELLER MA
GURSKI KJ
MURAKAMI M
DANIEL RW
SHAH KV
CELIS E
SETTE A
TRIMBLE EL
PARK RC
MARINCOLA FM
Citation: Ma. Steller et al., CELL-MEDIATED IMMUNOLOGICAL RESPONSES IN CERVICAL AND VAGINAL-CANCER PATIENTS IMMUNIZED WITH A LIPIDATED EPITOPE OF HUMAN-PAPILLOMAVIRUS TYPE-16 E7, Clinical cancer research, 4(9), 1998, pp. 2103-2109
Citation: Ka. Munoz et al., PATTERNS OF CARE FOR WOMEN WITH OVARIAN-CANCER IN THE UNITED-STATES, Journal of clinical oncology, 15(11), 1997, pp. 3408-3415
Authors:
TEJEDA HA
GREEN SB
TRIMBLE EL
FORD L
HIGH JL
UNGERLEIDER RS
FRIEDMAN MA
BRAWLEY OW
Citation: Ha. Tejeda et al., REPRESENTATION OF AFRICAN-AMERICANS, HISPANICS, AND WHITES IN NATIONAL-CANCER-INSTITUTE CANCER-TREATMENT TRIALS, Journal of the National Cancer Institute, 88(12), 1996, pp. 812-816
Citation: El. Trimble et Vl. Seltzer, FAMILY HISTORY AND RISK OF OVARIAN-CANCER - REPLY, JAMA, the journal of the American Medical Association, 274(5), 1995, pp. 383-383
Citation: El. Trimble, THE NIH CONSENSUS CONFERENCE ON OVARIAN-CANCER - SCREENING, TREATMENT, AND FOLLOW-UP - INTRODUCTION, Gynecologic oncology, 55(3), 1994, pp. 1-3
Authors:
TRIMBLE EL
ADAMS JD
VENA D
HAWKINS MJ
FRIEDMAN MA
FISHERMAN JS
CHRISTIAN MC
CANETTA R
ONETTO N
HAYN R
ARBUCK SG
Citation: El. Trimble et al., PACLITAXEL FOR PLATINUM-REFRACTORY OVARIAN-CANCER - RESULTS FROM THE FIRST 1,000 PATIENTS REGISTERED TO NATIONAL-CANCER-INSTITUTE TREATMENT-REFERRAL-CENTER-9103, Journal of clinical oncology, 11(12), 1993, pp. 2405-2410